Gulf Pharmaceutical Industries P.S.C Full Year 2023 Earnings: د.إ0.09 loss per share (vs د.إ0.029 loss in FY 2022)

Gulf Pharmaceutical Industries P.S.C (ADX:JULPHAR) Full Year 2023 Results

Key Financial Results

• Revenue: د.إ1.64b (up 1.4% from FY 2022).
• Net loss: د.إ103.6m (loss widened by 206% from FY 2022).
• د.إ0.09 loss per share (further deteriorated from د.إ0.029 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gulf Pharmaceutical Industries P.S.C Earnings Insights

The primary driver behind last 12 months revenue was the Planet segment contributing a total revenue of د.إ1.07b (65% of total revenue). Notably, cost of sales worth د.إ1.09b amounted to 67% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to د.إ375.3m (58% of total expenses). Explore how JULPHAR's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Pharmaceuticals industry in Asia.

Performance of the market in United Arab Emirates.

The company's shares are down 3.0% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for Gulf Pharmaceutical Industries P.S.C you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.